Page last updated: 2024-10-20

toluene and Parkinsonian Disorders

toluene has been researched along with Parkinsonian Disorders in 3 studies

methylbenzene : Any alkylbenzene that is benzene substituted with one or more methyl groups.

Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duan, W1
Zhu, X1
Ladenheim, B1
Yu, QS1
Guo, Z1
Oyler, J1
Cutler, RG1
Cadet, JL1
Greig, NH1
Mattson, MP1
Liang, ZQ1
Li, YL1
Zhao, XL1
Han, R1
Wang, XX1
Wang, Y1
Chase, TN1
Bennett, MC1
Qin, ZH1
Cintra, A1
Aguirre, JA1
Andbjer, B1
Finnman, UB1
Hagman, M1
Agnati, LF1
Höglund, C1
Möller, A1
Fuxe, K1

Other Studies

3 other studies available for toluene and Parkinsonian Disorders

ArticleYear
p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism.
    Annals of neurology, 2002, Volume: 52, Issue:5

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apoptosis; bcl-2-Associated X Protein; Behavi

2002
NF-kappaB contributes to 6-hydroxydopamine-induced apoptosis of nigral dopaminergic neurons through p53.
    Brain research, 2007, May-11, Volume: 1145

    Topics: Active Transport, Cell Nucleus; Animals; Apoptosis; Benzothiazoles; DNA Fragmentation; Dopamine; Mal

2007
Subchronic toluene exposure in low concentrations produces signs of reduced dysfunction in the 6-hydroxydopamine lesioned nigrostriatal dopaminergic system of the rat.
    Neuroscience letters, 1999, Oct-15, Volume: 274, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Behavior, Animal; Denervation; Dopamine; Injec

1999